These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2577106)

  • 41. Chemistry of DNA alkylation and aralkylation.
    Dipple A; Moschel RC
    Prog Clin Biol Res; 1990; 340A():71-80. PubMed ID: 2201980
    [No Abstract]   [Full Text] [Related]  

  • 42. Mono and bis(bioreductive) alkylating agents: synthesis and antitumor activities in a B16 melanoma model.
    Witiak DT; Loper JT; Ananthan S; Almerico AM; Verhoef VL; Filppi JA
    J Med Chem; 1989 Jul; 32(7):1636-42. PubMed ID: 2738896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlations of alkylating activity and mutagenicity in bacteria of cytostatic drugs.
    Hemminki K; Kallama S; Falck K
    Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):421-8. PubMed ID: 6659971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The influence of some alkylating antiblastic drugs and antimetabolites on the healing process of fracture foci. (Experimental research)].
    Mangione F; Taverna L
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1711-2. PubMed ID: 5877911
    [No Abstract]   [Full Text] [Related]  

  • 45. The letal action of monofunctional and bifunctional alkylating agents on T7 coliphage.
    Verly WG; Brakier L
    Biochim Biophys Acta; 1969 Feb; 174(2):674-85. PubMed ID: 5776190
    [No Abstract]   [Full Text] [Related]  

  • 46. [Formation of precipitation areas in immunization with the alkylating compounds Lonin-3 and K-4].
    Montsevichiute-Eringene
    Biull Eksp Biol Med; 1968 Mar; 65(3):91-4. PubMed ID: 4967813
    [No Abstract]   [Full Text] [Related]  

  • 47. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
    Coley HM; Mongelli N; D'Incalci M
    Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors.
    Teicher BA; Chatterjee D; Liu JT; Holden SA; Ara G
    Cancer Chemother Pharmacol; 1993; 32(4):315-9. PubMed ID: 8324874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A comparative analysis of the antiblastic and immunodepressive effect of alkylating agents].
    Kovalev IE; Chernov VA; Maĭskaia LM
    Vopr Onkol; 1969; 15(6):62-4. PubMed ID: 5811126
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparison of the effects of alkylating agents, antimetabolites and antineoplastic agents of other types on hemopoietic CFU in mice].
    Massa G; Saviane A; Bogliolo G; Pannacciulli I
    Boll Soc Ital Biol Sper; 1976 Mar; 52(6):460-4. PubMed ID: 949425
    [No Abstract]   [Full Text] [Related]  

  • 51. Peptide-linked 1,3-dialkyl-3-acyltriazenes: gastrin receptor directed antineoplastic alkylating agents.
    Schmidt BF; Hernandez L; Rouzer C; Czerwinski G; Chmurny G; Michejda CJ
    J Med Chem; 1994 Oct; 37(22):3812-8. PubMed ID: 7966139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A study of the effects of some antineoplastic preparations on human tumor cells (HeLa line) in tissue culture by the time lapse microphotography method].
    Shirokova TG; Larionov LF; Komm SG
    Tsitologiia; 1967 Apr; 9(4):483-6. PubMed ID: 4864556
    [No Abstract]   [Full Text] [Related]  

  • 53. PENETRATION OF BRAIN AND BRAIN TUMORS BY INTRAVASCULAR INJECTION OF ALKYLATING AGENTS. IV.
    SOLOWAY AH; NYILAS E; KJELLBERG RN; MARK VH
    J Med Pharm Chem; 1962 Nov; 5():1371-6. PubMed ID: 14056472
    [No Abstract]   [Full Text] [Related]  

  • 54. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Tumor chemotherapy. I. Chemical review of synthetic antineoplastic agents].
    Artico M
    Farmaco Sci; 1971 Feb; 26(2):156-90. PubMed ID: 5542973
    [No Abstract]   [Full Text] [Related]  

  • 56. [Elimination of I cells and inhibition of planulametamorphosis by alkylating cytostatics].
    Müller W
    Naturwissenschaften; 1966 Apr; 53(7):184-5. PubMed ID: 4383600
    [No Abstract]   [Full Text] [Related]  

  • 57. DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II).
    Lee HH; Palmer BD; Baguley BC; Chin M; McFadyen WD; Wickham G; Thorsbourne-Palmer D; Wakelin LP; Denny WA
    J Med Chem; 1992 Aug; 35(16):2983-7. PubMed ID: 1501223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Alkylating nucleosides. Synthesis and cytostatic activity of new types of halomethyl-substituted nucleosides].
    Pérez Méndez-Castrillón MP
    Rev Esp Oncol; 1984; 31(1):7-13. PubMed ID: 6545430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conceptual basis for use of chemotherapeutic agents and their pharmacology.
    Vietti TJ; Valeriote FA
    Pediatr Clin North Am; 1976 Feb; 23(1):67-92. PubMed ID: 176622
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of the chemical structure on the biological tendency of cytostatic compounds related to dibromomanitol. II. Mechanism of action.
    Horváth IP; Institóris L
    Arzneimittelforschung; 1967 Feb; 17(2):149-55. PubMed ID: 5631482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.